Insight Molecular Diagnostics (IMDX) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Insight Molecular Diagnostics (IMDX) over the last 4 years, with Q3 2025 value amounting to -$0.34.
- Insight Molecular Diagnostics' EPS (Weighted Average and Diluted) rose 6530.61% to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.88, marking a year-over-year increase of 4268.29%. This contributed to the annual value of -$4.67 for FY2024, which is 112111.54% down from last year.
- According to the latest figures from Q3 2025, Insight Molecular Diagnostics' EPS (Weighted Average and Diluted) is -$0.34, which was up 6530.61% from -$0.3 recorded in Q2 2025.
- Insight Molecular Diagnostics' 5-year EPS (Weighted Average and Diluted) high stood at $0.0 for Q1 2023, and its period low was -$8.16 during Q4 2022.
- Its 4-year average for EPS (Weighted Average and Diluted) is -$1.37, with a median of -$0.89 in 2024.
- Per our database at Business Quant, Insight Molecular Diagnostics' EPS (Weighted Average and Diluted) soared by 10073.64% in 2023 and then plummeted by 13764215.15% in 2024.
- Insight Molecular Diagnostics' EPS (Weighted Average and Diluted) (Quarter) stood at -$8.16 in 2022, then soared by 90.07% to -$0.81 in 2023, then crashed by 217.63% to -$2.57 in 2024, then soared by 86.78% to -$0.34 in 2025.
- Its last three reported values are -$0.34 in Q3 2025, -$0.3 for Q2 2025, and -$0.26 during Q1 2025.